Cargando…

Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United States

Detalles Bibliográficos
Autores principales:	Goyal, Gaurav, Magnusson, Tylan, Wang, Xiaoliang, Roose, James, Narkhede, Mayur, Seymour, Erlene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071129/ https://www.ncbi.nlm.nih.gov/pubmed/36453108 http://dx.doi.org/10.3324/haematol.2022.281461

Ejemplares similares

Evaluating real-world treatment patterns and outcomes of mantle cell lymphoma
por: Narkhede, Mayur, et al.
Publicado: (2022)

Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
por: Zhang, Jibin, et al.
Publicado: (2022)

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016)

CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challenges
por: Narkhede, Mayur, et al.
Publicado: (2021)

Primary effusion lymphoma: current perspectives
por: Narkhede, Mayur, et al.
Publicado: (2018)

Decreased CD11c‐positive dendritic cells in the tumor microenvironment predict double‐hit/triple‐hit genotype and survival in diffuse large B‐cell lymphoma
por: Yuan, Chang‐Tsu, et al.
Publicado: (2022)

Triple hit effect
por: Dixit, Ramakant, et al.
Publicado: (2015)

De Novo CD5-Positive Primary Gastric Diffuse Large B-Cell Lymphoma Coexpressing MYC and BCL6: Towards a Proper Subset of Double-Hit, Triple-Hit and, Maybe, Quadruple-Hit B-Cell Lymphomas?
por: Roncati, Luca
Publicado: (2018)

Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
por: Kim, Heyjin, et al.
Publicado: (2020)

Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
por: Kang, Junnan, et al.
Publicado: (2021)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

Survivin expression in patients with newly diagnosed nodal diffuse large B cell lymphoma (DLBCL)
por: Markovic, O., et al.
Publicado: (2012)

Paraneoplastic Necrotizing Myelopathy in a Patient With Newly Diagnosed Diffuse Large B Cell Lymphoma
por: Lee, Chau Hung, et al.
Publicado: (2011)

Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma
por: Yoshida, Masahiro, et al.
Publicado: (2021)

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
por: Walker, Brian A., et al.
Publicado: (2018)

Genetic diversity of newly diagnosed follicular lymphoma
por: Asmann, Y W, et al.
Publicado: (2014)

Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
por: Wu, Cheng-Han, et al.
Publicado: (2022)

Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement
por: Lehners, Nicola, et al.
Publicado: (2017)

Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
por: Seymour, Erlene K.
Publicado: (2019)

Isolated orbital mass as the primary presentation of a triple-hit lymphoma transformed from a systemic follicular lymphoma
por: Zhou, Xiao Yi, et al.
Publicado: (2018)

Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2016)

The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma
por: Yoon, Sang Eun, et al.
Publicado: (2023)

Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
por: Baysal, Mehmet, et al.
Publicado: (2020)

Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers
por: Almeida, Rui, et al.
Publicado: (2022)

Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma
por: Liang, Jin-Hua, et al.
Publicado: (2016)

Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement
por: Kojima, Minoru, et al.
Publicado: (2020)

Reduced-Intensity Anthracycline-Free Chemoimmunotherapy in Elderly Patients With Newly Diagnosed or Relapsed Diffuse Large B-Cell Lymphoma
por: Yohannan, Binoy, et al.
Publicado: (2023)

The prognosis of MYC translocation positive diffuse large B‐cell lymphoma depends on the second hit
por: Clipson, Alexandra, et al.
Publicado: (2015)

Advancing the management of double hit lymphoma
por: Landsburg, Daniel J.
Publicado: (2017)

Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019)

Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma
por: Chen, Yumei, et al.
Publicado: (2018)

Apparent diffusion coefficient as a valuable quantitative parameter for predicting clinical outcomes in patients with newly diagnosed primary CNS lymphoma
por: Baek, Dong Won, et al.
Publicado: (2020)

The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study
por: Li, Jiwei, et al.
Publicado: (2021)

Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study
por: Yang, Guang-Zhong, et al.
Publicado: (2021)

Triple Lymphoma and Transformation to Diffuse Large B-Cell Lymphoma Finding at the Time of Diagnosis
por: Rahim, Yaser, et al.
Publicado: (2023)

Rhabdomyosarcoma masquerading as lymphadenopathy in a patient with newly diagnosed Hodgkin’s lymphoma
por: Dergan, Joseph, et al.
Publicado: (2016)

Advances in the treatment of newly diagnosed primary central nervous system lymphomas
por: Qian, Liren, et al.
Publicado: (2017)

Prevalence and the impact of hypogammaglobulinemia in newly diagnosed chronic lymphocytic lymphoma patients
por: Singh, Namrata, et al.
Publicado: (2020)

Correlation of pretreatment (18)F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma
por: Huang, Honghui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ebvp4eica27d1bvleo6h3jpgrj